C

Celldex Therapeutics
D

CLDX

22.070
USD
-0.38
(-1.69%)
مفتوح الان
حجم التداول
9,072
الربح لكل سهم
-3
العائد الربحي
-
P/E
-9
حجم السوق
1,464,880,731
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    7.09
    (2.34%)
    310.36 USD
    AZN
    AZN
    0.700
    (0.94%)
    74.800 USD
    BMY
    BMY
    1.915
    (3.43%)
    57.755 USD
    GILD
    GILD
    1.250
    (1.14%)
    111.170 USD
    MRK
    MRK
    1.820
    (2.03%)
    91.090 USD
    NVS
    NVS
    0.100
    (0.09%)
    109.390 USD
    PFE
    PFE
    0.250
    (0.95%)
    26.575 USD
    المزيد
الأخبار
المقالات

العنوان: Celldex Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.